SCHEMBL3099980

SCHEMBL3099980

CCSc1cc(C)c2ccc(F)cc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ HBB P68871 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ KMT2A Q03164 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ MAPT P10636 5/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ POLB P06746 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ PRNP P04156 2/20 0.41
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ MPO P05164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3105741 0.88 GAA (0.48) TSHRKMT2AMEN1CYP2C9CYP2C19
SCHEMBL12803452 0.84 GAA (0.50) TSHRL3MBTL1HBBHSD17B10KMT2A
SCHEMBL3098810 0.79 L3MBTL1 (0.71) TSHRL3MBTL1HBBHSD17B10KMT2A
SCHEMBL14960133 0.74 POLB (0.61) KMT2AMEN1CYP2C19MAPTALDH1A1
SCHEMBL12804121 0.74 GAA (0.65) TSHRKMT2AMEN1CYP2C9CYP2C19
SCHEMBL5437258 0.71 KDM4E (0.49) KMT2AMEN1CYP2C19MAPTALDH1A1
SCHEMBL5440887 0.71 MPO (0.46) TSHRHSD17B10KMT2AMEN1MAPT
SCHEMBL3101342 0.71 ELANE (0.43) TSHRL3MBTL1HSD17B10KMT2ACYP2C9
SCHEMBL3093630 0.71 RXFP1 (0.49) TSHRL3MBTL1HSD17B10KMT2AMEN1
SCHEMBL3111650 0.70 POLB (0.71) TSHRL3MBTL1HBBHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399673-B2 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-03-19 — — US disclosed
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators DRUNENTHAL GMBH (DE) 2012-10-04 — — US disclosed
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNJ2 TSHR 3819/4885L3MBTL1 4153/4885HBB 4356/4885
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators KCNQ1, KCNQ2, KCNJ2 TSHR 3819/4885L3MBTL1 4153/4885HBB 4356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback